BILIRUBIN PROCEDURE, TEKPOINT TOT & DIR.

Diazo Colorimetry, Bilirubin

ICN PHARMACEUTICALS, INC.

The following data is part of a premarket notification filed by Icn Pharmaceuticals, Inc. with the FDA for Bilirubin Procedure, Tekpoint Tot & Dir..

Pre-market Notification Details

Device IDK770458
510k NumberK770458
Device Name:BILIRUBIN PROCEDURE, TEKPOINT TOT & DIR.
ClassificationDiazo Colorimetry, Bilirubin
Applicant ICN PHARMACEUTICALS, INC. 13 MOUNTAINVIEW AVE. ORANGEBURG,  NY  10962
Product CodeCIG  
CFR Regulation Number862.1110 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1977-03-08
Decision Date1977-05-10

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.